BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10465153)

  • 1. Accuracy of repeated blood sampling in rats: a new technique applied in pharmacokinetic/pharmacodynamic studies of the interaction between warfarin and co-enzyme Q10.
    Zhou Q; Chan E
    J Pharmacol Toxicol Methods; 1998 Nov; 40(4):191-9. PubMed ID: 10465153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ubidecarenone on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats.
    Zhou S; Chan E
    Drug Metabol Drug Interact; 2001; 18(2):99-122. PubMed ID: 11460879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of High Altitude Environment on Pharmacokinetic and Pharmacodynamic of Warfarin in Rats.
    Zhang X; Mu H; Zhong Y; Wang R; Li W
    Curr Drug Metab; 2024; 25(1):54-62. PubMed ID: 38409697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 5-fluorouracil on the anticoagulant activity and the pharmacokinetics of warfarin enantiomers in rats.
    Zhou Q; Chan E
    Eur J Pharm Sci; 2002 Oct; 17(1-2):73-80. PubMed ID: 12356422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of multiple doses of donepezil HCl on the pharmacokinetic and pharmacodynamic profile of warfarin.
    Tiseo PJ; Foley K; Friedhoff LT
    Br J Clin Pharmacol; 1998 Nov; 46 Suppl 1(Suppl 1):45-50. PubMed ID: 9839766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic and stereoselective pharmacokinetic interactions between zileuton and warfarin in humans.
    Awni WM; Hussein Z; Granneman GR; Patterson KJ; Dubé LM; Cavanaugh JH
    Clin Pharmacokinet; 1995; 29 Suppl 2():67-76. PubMed ID: 8620673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical pharmacokinetic and pharmacodynamic drug-herb interactions in rats between warfarin and pomegranate peel or guava leaves extracts.
    Alnaqeeb M; Mansor KA; Mallah EM; Ghanim BY; Idkaidek N; Qinna NA
    BMC Complement Altern Med; 2019 Jan; 19(1):29. PubMed ID: 30678660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of fenofibric acid on the pharmacokinetics and pharmacodynamics of warfarin in rats.
    Guo C; Xue S; Zheng X; Lu Y; Zhao D; Chen X; Li N
    Xenobiotica; 2018 Apr; 48(4):400-406. PubMed ID: 28287050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of cimetidine on the steady-state pharmacokinetics and pharmacodynamics of warfarin in humans.
    Niopas I; Toon S; Aarons L; Rowland M
    Eur J Clin Pharmacol; 1999 Jul; 55(5):399-404. PubMed ID: 10456491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations.
    Palareti G; Legnani C
    Clin Pharmacokinet; 1996 Apr; 30(4):300-13. PubMed ID: 8983860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic interaction of Danshen-Gegen extract with warfarin and aspirin.
    Zhou L; Wang S; Zhang Z; Lau BS; Fung KP; Leung PC; Zuo Z
    J Ethnopharmacol; 2012 Sep; 143(2):648-55. PubMed ID: 22867637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of Shuxuetong injection on anticoagulant effect of warfarin in rats].
    Zhao HF; Sun JH; Liu S; Liu Y; Liu GF
    Zhongguo Zhong Yao Za Zhi; 2017 Mar; 42(5):982-988. PubMed ID: 28994544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the relative sensitivities of factor VII and prothrombin time measurements in detecting drug interactions with warfarin.
    Pitsiu M; Parker EM; Aarons L; Holt B; Rowland M
    Eur J Clin Pharmacol; 1992; 42(6):645-9. PubMed ID: 1623906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent effects of raloxifene HCI on the pharmacokinetics and pharmacodynamics of warfarin.
    Miller JW; Skerjanec A; Knadler MP; Ghosh A; Allerheiligen SR
    Pharm Res; 2001 Jul; 18(7):1024-8. PubMed ID: 11496940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of pharmacokinetic and pharmacodynamic interactions when lenalidomide is co-administered with warfarin in a randomized clinical trial setting.
    Weiss D; Knight R; Zhou S; Palmisano M; Chen N
    Clin Drug Investig; 2015 Jul; 35(7):455-61. PubMed ID: 26024727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetic and Pharmacodynamic Analyses of Drug-Drug Interactions between Iguratimod and Warfarin].
    Yamamoto T; Hasegawa K; Onoda M; Tanaka K
    Yakugaku Zasshi; 2016; 136(6):905-11. PubMed ID: 27252068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats.
    Zhu M; Chan KW; Ng LS; Chang Q; Chang S; Li RC
    J Pharm Pharmacol; 1999 Feb; 51(2):175-80. PubMed ID: 10217316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant effect of capecitabine on the pharmacokinetics and pharmacodynamics of warfarin in patients with cancer.
    Camidge R; Reigner B; Cassidy J; Grange S; Abt M; Weidekamm E; Jodrell D
    J Clin Oncol; 2005 Jul; 23(21):4719-25. PubMed ID: 16034047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of Compound Danshen Dripping Pills, a Chinese herb medicine, on the pharmacokinetics and pharmacodynamics of warfarin in rats.
    Chu Y; Zhang L; Wang XY; Guo JH; Guo ZX; Ma XH
    J Ethnopharmacol; 2011 Oct; 137(3):1457-61. PubMed ID: 21878380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of the anticoagulation effect of warfarin by the herbal remedy Shu-Jing-Hwo-Shiee-Tang in rats: The dosing regimen and pharmacokinetic interaction.
    Ueng YF; Lu CK; Yang SH; Wang HJ; Huang CC
    Drug Metab Pharmacokinet; 2017 Feb; 32(1):85-91. PubMed ID: 28111103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.